Emerald Health Therapeutics, Inc. has announced the launch of Verdélite Sciences Inc. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes.
Emerald is nearing completion of its over $100 million investment to expand its multi-purpose facility to 88,000 square feet and enable the complete cycle of indoor cultivation, product development and automated packaging of cannabis products. "Upon reaching full production levels in mid-2019, Verdélite projects it will have created approximately 140 jobs.", the company says.
"In addition to 23 growing rooms, the facility will include an analytical testing laboratory as well as a research centre for product innovation and extraction technology. These capabilities will also position Verdélite to participate in the development and production of edible cannabis products, which are expected to be sanctioned by Health Canada by October 17, 2019."
Emerald acquired Verdélite in May 2018 with an operating footprint of 25,000 square feet. The full 88,000 square foot facility is expected to be operational in Q2 2019, with approximately 50,000 square feet of cannabis flowering capacity in precision-controlled environments. Verdélite possesses approximately 200 strains of cannabis.
For more information:
Emerald Health Therapeutics